首页> 外文期刊>Frontiers in Pharmacology >Jia-Wei-Kai-Xin-San, an Herbal Medicine Formula, Ameliorates Cognitive Deficits via Modulating Metabolism of Beta Amyloid Protein and Neurotrophic Factors in Hippocampus of Aβ 1-42 Induced Cognitive Deficit Mice
【24h】

Jia-Wei-Kai-Xin-San, an Herbal Medicine Formula, Ameliorates Cognitive Deficits via Modulating Metabolism of Beta Amyloid Protein and Neurotrophic Factors in Hippocampus of Aβ 1-42 Induced Cognitive Deficit Mice

机译:草药方开胃开心散通过调节β淀粉样蛋白的代谢和Aβ 1-42 诱导的认知缺陷小鼠海马中的神经营养因子改善认知功能障碍

获取原文

摘要

Jia-Wei-Kai-Xin-San (JWKXS) is a Chinese medicine formula applied for treating morbid forgetfulness in ancient China. Today, this formula is frequently applied for Alzheimer’s disease and vascular dementia (VD) in clinic. Here, we developed it as granules and aimed to evaluate its anti-AD effect on β amyloid protein 1–42 (Aβ _(1-42)) induced cognitive deficit mice and reveal the possible molecular mechanisms. Firstly, daily intra-gastric administration of chemically standardized of JWKXS granules for 7 days significantly ameliorated the cognitive deficit symptoms and inhibited cell apoptosis in hippocampus on Aβ _(1-42) injection mice. JWKXS granules significantly decreased Aβ level, increased superoxide dismutase activity and decreased malondialdehyde level in hippocampus of model mice. It also restored acetylcholine amounts, inhibited acetylcholinesterase activities and increased choline acetyltransferase activities. In addition, JWKXS granules enabled the transformation of precursors of NGF and BDNF into mature forms. Furthermore, JWKXS granules could regulate gene expressions related to Aβ production, transportation, degradation and neurotrophic factor transformation, which led to down-regulation of Aβ and up-regulation of NGF and BDNF. These findings suggested that JWKXS granules ameliorated cognitive deficit via decreasing Aβ levels, protecting neuron from oxidation damages and nourishing neuron, which could serve as alternative medicine for patients suffering from AD.
机译:加味开新山(JWKXS)是一种用于治疗中国古代病态健忘的中药配方。如今,该配方在临床上经常用于阿尔茨海默氏病和血管性痴呆(VD)。在这里,我们将其开发为颗粒剂,旨在评估其对β淀粉样蛋白1-42(Aβ_(1-42))诱导的认知缺陷小鼠的抗AD作用,并揭示其可能的分子机制。首先,每天在胃内施用化学标准化的JWKXS颗粒7天,可显着改善Aβ_(1-42)注射小鼠海马的认知缺陷症状并抑制其细胞凋亡。 JWKXS颗粒可明显降低模型小鼠海马的Aβ水平,超氧化物歧化酶活性和降低丙二醛水平。它还可以恢复乙酰胆碱的量,抑制乙酰胆碱酯酶的活性并增加胆碱乙酰转移酶的活性。此外,JWKXS颗粒能够将NGF和BDNF的前体转化为成熟形式。此外,JWKXS颗粒可以调节与Aβ产生,转运,降解和神经营养因子转化有关的基因表达,从而导致Aβ下调以及NGF和BDNF上调。这些发现表明,JWKXS颗粒通过降低Aβ水平,保护神经元免受氧化损伤和滋养神经元来改善认知功能障碍,可作为患有AD的患者的替代药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号